DHR:NYSE
Danaher Corp
$207.90
arrow_downward
-1.48%(-3.13) 1D
Sep 4, 2:45:05 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DHR...
Open
$207.19
High
$208.70
Low
$205.23
Mkt. cap
146.15B
Avg. vol.
3.94M
Volume
1.75M
Dividend
0.77%
Quarterly dividend
$0.40
Ex-dividend date
Jun 26, 2026
P/E ratio
36.91
52-wk high
$242.80
52-wk low
$160.93
EPS
$5.63
Beta
0.78
Shares outstanding
702.99M
No. of employees
59K
Open
$207.19
High
$208.70
Low
$205.23
Mkt. cap
146.15B
Avg. vol.
3.94M
Volume
1.75M
Dividend
0.77%
Quarterly dividend
$0.40
Ex-dividend date
Jun 26, 2026
P/E ratio
36.91
52-wk high
$242.80
52-wk low
$160.93
EPS
$5.63
Beta
0.78
Shares outstanding
702.99M
No. of employees
59K
News stories
From web sources and news partners
AD HOC NEWS
·
5 hours ago
Danaher Corp. stock trades near 52-week highs as investors digest recent earnings
Zacks
·
7 hours ago
Is Revvity Stock a Buy as Growth Improves but Valuation Stays Rich?
Yahoo Finance
·
1 day ago
Danaher (DHR) Stock Trades Near Fair Value But At An Earnings Premium
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp